Inovio.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 23392500.
- Also identified by DOI 10.1038/nbt0213-98.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A Pennsylvania company hopes to turn synthetic DNA vaccines into rapid response agents against flu epidemics and cancer.
Medical subject headings
- Drug Industry
- Influenza, Human
- Neoplasms
- Vaccines, DNA